Xiamen Amoytop Biotech Co., Ltd. (688278.SS)
CNY 71.53
(1.26%)
CNY 71.53
(1.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 187.01 Million CNY | 44.16% |
| 2022 | 129.72 Million CNY | 11.36% |
| 2021 | 116.49 Million CNY | 16.94% |
| 2020 | 99.61 Million CNY | 41.11% |
| 2019 | 70.59 Million CNY | 27.71% |
| 2018 | 55.28 Million CNY | 33.46% |
| 2017 | 41.41 Million CNY | 33.44% |
| 2016 | 31.04 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 216.09 Million CNY | 15.55% |
| 2024 Q2 | 230.11 Million CNY | 6.49% |
| 2024 Q3 | 252.74 Million CNY | 9.84% |
| 2023 Q4 | 187.01 Million CNY | 9.18% |
| 2023 Q3 | 171.29 Million CNY | 11.79% |
| 2023 Q1 | 139.81 Million CNY | 7.78% |
| 2023 FY | 187.01 Million CNY | 44.16% |
| 2023 Q2 | 153.22 Million CNY | 9.59% |
| 2022 Q2 | 123.63 Million CNY | 4.36% |
| 2022 Q1 | 118.47 Million CNY | 1.7% |
| 2022 Q3 | 120.27 Million CNY | -2.72% |
| 2022 FY | 129.72 Million CNY | 11.36% |
| 2022 Q4 | 129.72 Million CNY | 7.86% |
| 2021 Q1 | 106.58 Million CNY | 7.0% |
| 2021 Q2 | 105.75 Million CNY | -0.79% |
| 2021 Q4 | 116.49 Million CNY | 3.09% |
| 2021 Q3 | 112.99 Million CNY | 6.85% |
| 2021 FY | 116.49 Million CNY | 16.94% |
| 2020 Q4 | 99.61 Million CNY | 6.6% |
| 2020 Q1 | 84.16 Million CNY | 19.21% |
| 2020 FY | 99.61 Million CNY | 41.11% |
| 2020 Q3 | 93.44 Million CNY | 0.63% |
| 2020 Q2 | 92.86 Million CNY | 10.34% |
| 2019 Q3 | 66.7 Million CNY | 4.43% |
| 2019 FY | 70.59 Million CNY | 27.71% |
| 2019 Q4 | 70.59 Million CNY | 5.84% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | 63.87 Million CNY | 0.0% |
| 2018 FY | 55.28 Million CNY | 33.46% |
| 2018 Q4 | 55.28 Million CNY | 0.0% |
| 2017 FY | 41.41 Million CNY | 33.44% |
| 2016 FY | 31.04 Million CNY | 0.0% |